prop65limits.com
Cancer & ReproductiveMADLIngestion

Di(2-ethylhexyl)phthalate (DEHP)

CAS 117-81-7

Safe harbor level
200 µg/day
Basis
MADL
Endpoint
Cancer & Reproductive

Di(2-ethylhexyl)phthalate (DEHP) (Cancer & Reproductive)

Di(2-ethylhexyl)phthalate (DEHP) is listed under California Proposition 65 for the Cancer & Reproductive endpoint. Its established safe harbor level is 200 µg/day as a MADL, determined for exposure primarily via the ingestion route. CAS registry number: 117-81-7.

Safe Harbor Level

Field Value
Chemical Di(2-ethylhexyl)phthalate (DEHP)
CAS Number 117-81-7
Toxicity Endpoint Cancer & Reproductive
Safe Harbor Basis MADL
Safe Harbor Level 200 µg/day
Primary Exposure Route Ingestion

What this level means

A MADL is a daily exposure level for Di(2-ethylhexyl)phthalate (DEHP) that — at or below 200 µg/day per day — does not require a Proposition 65 warning because it poses no significant risk for the Cancer & Reproductive endpoint. This is the Maximum Allowable Dose Level (MADL) — the daily intake for the reproductive/developmental endpoint.

Businesses that expose consumers to more than the safe harbor level for Di(2-ethylhexyl)phthalate (DEHP) must provide a clear and reasonable Prop 65 warning. Compliance is assessed against the applicable OEHHA safe harbor level above; where no safe harbor level is established, an exposure assessment may be required.

Compliance notes

  1. Compare the daily exposure to the MADL of 200 µg/day.
  2. If exposure exceeds the level, a Prop 65 warning is generally required.
  3. Confirm the current OEHHA listing and any updates to the level before relying on it — safe harbor levels are amended periodically.

Frequently Asked Questions

What is the Prop 65 safe harbor level for Di(2-ethylhexyl)phthalate (DEHP)?

200 µg/day per day (MADL).

What is the CAS number for Di(2-ethylhexyl)phthalate (DEHP)?

117-81-7.

What endpoint is Di(2-ethylhexyl)phthalate (DEHP) listed for?

Cancer & Reproductive.

What is the primary route of exposure for Di(2-ethylhexyl)phthalate (DEHP)?

The ingestion route.

What is the difference between an NSRL and a MADL?

An NSRL (No Significant Risk Level) applies to cancer endpoints; a MADL (Maximum Allowable Dose Level) applies to reproductive and developmental endpoints.

Related Cancer & Reproductive listings